Name | Fexaramine,3-[3-[(Cyclohexylcarbonyl)-[[4'-(dimethylamino)-[1,1'-biphenyl]-4-yl]methyl]amino]phenyl]-2-propenoicacidmethylester |
---|---|
Synonyms | Fexaramine |
Description | Fexaramine is a small molecule farnesoid X receptor (FXR) agonist with 100-fold increased affinity relative to natural compounds. IC50 value:Target:in vitro: In vitro treatment of CDCA or fexaramine elevated the SHP transcript level and occupancy on secretin promoter [1]. Fexaramine significantly enhanced osteoblastic differentiation through the upregulation of Runx2 and enhanced extracellular signal-regulated kinase (ERK) and β-catenin signaling [2]. By mimicking this tissue-selective effect, the gut-restricted FXR agonist fexaramine (Fex) robustly induces enteric fibroblast growth factor 15 (FGF15), leading to alterations in BA composition, but does so without activating FXR target genes in the liver [3]. |
---|---|
Related Catalog | |
References |
Density | 1.158g/cm3 |
---|---|
Boiling Point | 677.7ºC at 760 mmHg |
Molecular Formula | C32H36N2O3 |
Molecular Weight | 496.64000 |
Flash Point | 363.7ºC |
Exact Mass | 496.27300 |
PSA | 49.85000 |
LogP | 6.71930 |
Appearance | yellow solid |
Index of Refraction | 1.626 |
Storage condition | -20℃ |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H413 |
Precautionary Statements | P301 + P312 + P330 |
RIDADR | NONH for all modes of transport |